Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Degen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Dermatology : EJD|February 20, 2013
Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanomaAnnette Degen, Bernward Völker, Alexander Kapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapyImke Satzger, Annette Degen, Hiba Asper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Reply to N. Rompoti et alImke Satzger, Annette Degen, Hiba Asper, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 21, 2010
The hand-foot-syndrome associated with medical tumor therapy - classification and managementAnnette Degen, Mareike Alter, Florian Schenck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|February 20, 2013
Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanomaAnnette Degen, Bernward Völker, Alexander Kapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapyImke Satzger, Annette Degen, Hiba Asper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Reply to N. Rompoti et alImke Satzger, Annette Degen, Hiba Asper, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 21, 2010
The hand-foot-syndrome associated with medical tumor therapy - classification and managementAnnette Degen, Mareike Alter, Florian Schenck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Pageof 1